Connect your AI

Disc Medicine IRON Other Working Capital

Other Working Capital at other companies

Bristol-Myers SquibbBMY

$1.64B+54.5%

Protagonist TherapeuticsPTGX

-$2K-140%

Travere Therapeutics, Inc.TVTX

$4K-99.7%

BridgeBio PharmaBBIO

-$306K-1,557%

Other financials

Income statement

Operating income-$69.5M-74.0%

Net income-$63.5M-86.3%

EPS (diluted)-$1.65-61.8%

Balance sheet

Cash & equivalents$88.9M-27.5%

Total debt$31.1M+1.4%

Total equity$688.4M+4.3%

Total assets$750.2M+5.8%

Cash flow

Operating cash flow-$62.2M-50.4%

CapEx--100%

Free cash flow-$62.2M-47.4%

Valuation

Market cap$2.69B+42.2%

Enterprise value$2.63B+46.7%

Returns & leverage

Return on equity-35.8%+41.3pp

Debt / equity0×0.0×

Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Disc Medicine's other working capital?: Disc Medicine (IRON) reported other working capital of $12K in Q1 2026.
How has Disc Medicine's other working capital changed year-over-year?: Disc Medicine's other working capital increased by 180.0% year-over-year, from -$15K to $12K.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.